Innovating Works

RondelO

Financiado
RondelO - the first medical stopcock designed for sequential intraveneous infusi...
RondelO - the first medical stopcock designed for sequential intraveneous infusion of incompatible drugs CYTO365 is developing RondeO® - a revolutionary medical stopcock to be used with intravenous drug administration sets (IV sets). RondelO® is the first medical device that allows for a sequential intravenous administration of up to... CYTO365 is developing RondeO® - a revolutionary medical stopcock to be used with intravenous drug administration sets (IV sets). RondelO® is the first medical device that allows for a sequential intravenous administration of up to 6 drugs with the neutral saline in between the drugs. RondelO® aids the nurse to administer drugs to the patient safely and correctly, by letting only one drug pass at a time. It solves the problem of serious side effects caused by drug incompatibility by eliminating human error and unwanted parallel infusion and thereby increases patient safety. Moreover, RondelO® is easy to use (minimal training required), safe for the user (Closed System Valve (CSV) minimizes hazardous drug expose for the nurse), customizable (different configurations with 2, 4 or 6 drug inlets with or without CSV available) and time-efficient (all drugs are connected to IV set at the beginning of the procedure). ver más
30/04/2025
3M€
Duración del proyecto: 24 meses Fecha Inicio: 2023-04-14
Fecha Fin: 2025-04-30

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-14
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 3M€
Líder del proyecto
CYTO365 AB No se ha especificado una descripción o un objeto social para esta compañía.